Peptide Decoding
New?New to peptides?Start here →
Decoding

SHLP2_Dosage, benefits & legal status

Also known as small humanin-like peptide 2, SHLP-2, SHLP 2

Published August 24, 2026 · Updated October 4, 2026

A mitochondrial peptide with real published biology and no human dosing behind it.

Metabolic & agingMitochondrial-derived peptideResearch only
DoseResearch only
FrequencyNot established
RouteUnder the skin (subcutaneous)
StatusResearch only
CycledNot established

Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.

See how this dose compares across the library →

01

What is SHLP2?

Plain language first. The technical label stays, but it never stands alone.

Overview

A mitochondrial peptide with better published science than most things on this shelf, and still no human study of taking it. The research is in cells and mice.

The technical version

SHLP2, a mitochondrial-derived peptide encoded by a small open reading frame within the MT-RNR2 16S rRNA region. Reported to signal through CXCR7 and to bind mitochondrial complex 1. Preclinical data covers insulin sensitisation, POMC neuron activation, and cytoprotection in retinal and neuronal cell models. No human administration study has been published.

What it's used for

A mitochondrial peptide researched for insulin sensitivity, mitochondrial function and aging.

02

How does SHLP2 work?

What it does in the body, and where.

SHLP2 comes from the same discovery program as humanin and MOTS-c, both of which this library already covers.

  1. 01
    It is encoded inside mitochondrial DNA
    The Cohen lab at USC searched the 16S rRNA region of the mitochondrial genome for small open reading frames and found six, named SHLP1 to SHLP6, ranging from 20 to 38 amino acids.
  2. 02
    It binds a receptor, which most peptides in this category cannot claim
    A 2023 Nature Communications paper identified CXCR7 as the receptor SHLP2 activates, and reported that giving it to mice on a high-fat diet protected against obesity and improved insulin sensitivity through POMC neurons in the hypothalamus.
  3. 03
    It also binds mitochondrial complex 1
    Reported to increase respiration, reduce reactive oxygen species and raise levels of oxidative phosphorylation subunits in cell models.
03

What else is it used for?

Each use below carries its own evidence level. Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.

  • Insulin sensitivity and metabolic healthEarly research
  • Mitochondrial protection, including in macular degeneration cell modelsEarly research
  • Neuroprotection, including a Parkinson's disease variant findingEarly research
  • Anti-aging generally, which is the marketing framenone

The published record

Research index

28

Papers and trials about SHLP2

16 papers tagged human · 8 not reviews or lab · 0 clinical trial publications

Furthest stage reached: No clinical trial on record

Compare this against the whole library →

Evidence summary

Counted from Europe PMC indexing, not read by a person; a human tag can land on reviews, commentary or lab papers; clinical trial publications is the narrower count.

SHLP2 vial rendering
Compound field notes

At a glance

Four things to know about SHLP2

01

Evidence

Research only

02

Category

Longevity and energy

03

Common vial

Varies

04

Half-life

Nothing published

04

How much, and do you cycle it?

The range, and whether you take breaks.

Research only, not established. Not established No range

No schedule has been studied for this compound in people.

Compare this against the whole library →

05

How long does it stay in the body?

The half-life, and where the figure comes from.

Nothing publishedNo figure

No half-life has been published for SHLP2. Pharmacokinetic work in this family has been done on humanin and its analogs, and those figures belong to humanin.

You can compare this against the whole library to see where it sits.

06

How do I dose and price it?

Enter your vial and your dose. Pick a mix. We show the draw and the cost.

The vial holds a fixed amount of drug. Adding more water does not make more drug, it just spreads it thinner, so you draw a bigger number on the syringe for the same dose.

Your vial size (mg)
Enter the amount printed on your label.
What you paid per vial
$
Used for cost per dose only.
Your dose (mg)
Commonly referenced range: 1 up to 5 mgCommunity practice

Choose your mix

your own mL
units · —
Enter your own volume

Measuring the water1 mL = one full 100-unit syringe.

YOUR DRAW0 / 100 units
07

How do you store it?

Before mixing, and after.

Dry powder in the freezer or fridge. Once mixed, fridge, and use within about a month.

Unmixed lyophilized SHLP2 keeps for a long time cold. Once you add water the clock starts: most reconstituted vials hold up for roughly 28 to 30 days at fridge temperature. Keep it out of light, and do not freeze it after mixing.

08

What are the side effects and cautions?

Known cautions and warnings for this compound.

Solubility, computed: 19% charged residues, 54% hydrophobic. Organic co-solvent likely.

A first-pass rule from peptide manufacturers' guidance. It does not account for disulfide bridges, salt form or how the powder was dried, and it predicts what should be easy rather than what will happen in your vial.

Who should avoid it

Check these before anything else.
  • Pregnancy or breastfeeding
  • Active cancer, as a precaution with anything affecting cell survival signaling
  • Anyone who wants established safety data, because none exists for this compound in humans

Stop and get help

These are emergencies. Seek care.
  • Signs of an allergic reaction, including spreading hives, facial or throat swelling, or trouble breathing
  • Redness, heat, or pus at the injection site, which can signal infection
  • Anything unusual, since there is no known safety profile to compare it against

Common effects

Expected, and usually mild.
  • Unknown. No study has recorded what this commonly causes in people
  • Redness, soreness, or a small bump at the injection site

Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.

09

Is SHLP2 approved?

And where the numbers on this page come from.

No. SHLP2 is not approved for any use, anywhere. It is sold labeled for laboratory research only, and there is no legal route to buy it for human use.

  • Approval status
    Research only
  • Route
    Under the skin (subcutaneous)
  • Checked
    24 August 2026
  • Dose
    From community reports. No regulator or trial established this dose.
  • Vial size
    From what vendors typically list; not a recommendation.
  • Sources
    None traced yet.

What has happened recently

We have not yet written a full regulatory note for this compound. The status above is current as of the date shown.

Guides for this compound

Sources

No primary source has been traced for this compound yet. Treat everything on this page as unverified until one is. How we grade evidence

Beyond these, 28 records are indexed. Browse the records